Online Submissions

Already have a Username/Password for Translational Medicine?
Go to Login

Need a Username/Password?
Go to Registration

Registration and login are required to submit items online and to check the status of current submissions.

Author Guidelines

Updated: 06.07.2026

GENERAL RULES

The general criteria for manuscripts accepted for publication in the journal Translational Medicine are the manuscript's relevance to the journal's scientific scope, the timeliness of the work, and the novelty of the presented results. Manuscripts that have not been previously published in other journals are accepted. Authors must ensure that the manuscript materials have not been submitted for publication to other journals (in any language).

Manuscripts are accepted for review in electronic format (doc/docx) and must be submitted to the editorial office via the online submission system on the website. The recommended manuscript length is 10–20 pages for an original article or review, and 4–5 pages for clinical cases and brief communications.

Text originality must be at least 80 %, while the percentage of self-citation should not exceed 10–15 %. The originality report from the Anti-Plagiarism system for each manuscript is reviewed on a case-by-case basis by the Executive Secretary. In the event of any disputed issues, the report is evaluated by the Scientific Editor. The Editorial Office independently conducts plagiarism screening of all submitted manuscripts.

The text must be formatted with a white background in black, 14-point Times New Roman font, with 1.5 line spacing and 20 mm margins. All pages must be numbered; line numbering within the text is also highly recommended.

The following official documents must be appended to the manuscript:

1. Official referral letter from the institution where the work was performed, addressed to the Editor-in-Chief, containing:
• a brief description of the submitted work and its significance;
• the novelty of the obtained results;
• the type of article (review, clinical study, clinical case, original research, etc.).
2. Cover letter regarding the absence of conflicts of interest among the authors, signed by all co-authors. The cover letter must specify whether the article is based on dissertation research. If it is, the first page of the manuscript must be endorsed by the research supervisor.
3. For any scientific article involving human or animal subjects, a copy of the approval from the Local Ethics Committee must be appended, specifying the meeting location, date, and protocol number.
4. Graphical Abstract. A graphical abstract is an image that visually represents the key findings of the scientific article. Authors are required to prepare a figure that clearly illustrates the research problem and upload it to the editorial office along with the manuscript. Graphical abstracts, like the articles themselves, undergo mandatory peer review.

Key requirements for the graphical abstract:

• format: JPEG;
• the abstract should convey the core essence of the work, avoiding secondary details;
• include only the most essential information; overcrowding hinders comprehension;
• all captions and labels must be in Russian;
• the image should be neither overly simplistic nor overloaded;
• diagrams and schemes are preferred.

To prepare the graphical abstract, authors may use various analytical resources, such as https://datalens.ru/.

1. A list of three (or more) potential reviewers for the manuscript, including their full names and email addresses. These must be specialists in the field of the submitted manuscript who are capable of conducting an expert evaluation. To avoid conflicts of interest, authors and potential reviewers must not have co-authored publications within the previous five years and must not belong to the same research group. If necessary, you may specify reviewers to whom you would prefer not to send the work for review.

MANUSCRIPT FORMATTING REQUIREMENTS

Authors are strongly recommended to use the provided template for proper manuscript formatting.

The manuscript should be formatted according to the sample and include the following sections:

• title page;
• abstract;
• keywords;
• main text;
• conflict of interest;
• funding (if applicable);
• compliance with ethical principles;
• acknowledgments (if applicable);
• references;
• authors information;
• authors' contributions.

Additionally, the following files should be uploaded separately to the editorial office:

• figures;
• tables.

1. Title Page

The manuscript title should be written in bold type using sentence case (lowercase letters), without hyphenation.

Authors' last names and initials should be formatted as follows: e.g., I. I. Ivanov, P. P. Petrov. Last names in English must match the transliteration used in the author's previously published articles and profiles in international databases. If the author has no prior publications, the BSI transliteration standard must be used for both the first and last names (https://translit.ru/ru/bsi/).

The full official name(s) of the institution(s) (as per the institutional charter) from which the manuscript originated, along with the city and country, must be provided. The English translation of institutional names must also be official.

Footnotes should be indicated with Arabic numerals placed after the authors' names and before the institution names.

In this section, the corresponding author must be designated. The corresponding author acts as the primary contact person between the publisher and the co-authors. They are responsible for informing co-authors and involving them in publication-related decisions (e.g., when responding to reviewer comments). The full name, affiliation, and contact details (email and phone number) of the corresponding author must be provided.

The title page must be submitted in both Russian and English.

2. Abstract and Keywords

The manuscript abstract must be submitted in both Russian and English. The recommended length for the Russian-language abstract is 220–240 words. The English-language abstract must be a complete, semantically accurate translation of the Russian version, adapted for an international scientific audience (stylistically correct, clear, and natural). For original articles, the abstract must be structured and include 5 sections: Background, Objective, Methods / Materials and Methods, Results, and Conclusion. For reviews and brief communications, an unstructured abstract is permitted.

Following the abstract in each language, Keywords must be provided (at least 6 and no more than 10 words or phrases), presented in the singular form and nominative case (keywords are included in the overall abstract word count). It is not recommended to include common words lacking specific meaning, overly long phrases (unless they are established terms), abbreviations, or fixed idioms.

3. Manuscript Sections

3.1. List of Abbreviations

Abbreviations occurring more than three times should be listed. Upon first mention in the text, the abbreviation must be accompanied by the full term, with the abbreviation given in parentheses. For example: blood pressure (BP). Abbreviations appearing only in tables and figures, but not in the main text, should not be included in the list of abbreviations; instead, they must be defined in the notes to the respective table or figure, including their English translation. If abbreviations are listed at the very beginning of the article, they do not need to be translated into English within that list. Abbreviations must be standard and clear to the reader, in accordance with scientific literature norms. Abbreviations identical in spelling to others with different meanings are strongly discouraged. Abbreviations in the list are written in alphabetical order, separated by commas.

Example: BP – blood pressure, HR – heart rate.

3.2. Main Text

The text of original research manuscripts must be structured. The following sections must be included: Introduction, Materials and Methods, Results, Discussion, and Conclusion. The text of reviews and clinical cases may remain unstructured.

Data must be presented using the SI system. The percent sign  is separated from the number by a space. The p-value is written with a decimal point: p<0.0001. The n-value is written in lowercase (n=20). The signs >, <, ±, =, +, and - are written without spaces between numerical values. The word “year” or “years” is formatted as, for example, 2014 or 2002–2014. An en dash (–) must be used in the text. If a number has five or more digits, spaces are used to separate groups of three digits from the right: 89 645, 4 028 880.

3.3. Conflict of Interest

In the absence of a conflict of interest, the journal uses the following standard wording:

Conflict of interest

The authors declare no conflict of interest.

If there is any conflict of interest, an appropriate disclosure statement must be made.

3.4. Funding

Specified if applicable. The grant number and a stable link or reference must be provided. Translation into English is mandatory.

3.5. Compliance with Ethical Principles (see website: https://transmed.almazovcentre.ru/jour/about/editorialPolicies#custom-1)

Authors must state that their work complies with ethical standards. When mentioning patients, authors must indicate that signed informed consents have been obtained and that the study has been approved by the Local Ethics Committee.

Standard wording used by the journal:

The study was approved by the Local Ethics Committee (location, date, and protocol number). All patients signed informed consent for the publication of the research data.

For studies involving animals, authors must reference bioethical rules that comply with international standards. In all cases, authors must indicate whether the study protocol was approved by an ethics committee (providing the protocol number, location, and date of the committee meeting).

Authors are required to disclose the use of generative artificial intelligence tools in their manuscripts. If AI tools were not used, the following standard wording must be included:

The authors declare no use of Generative AI in the preparation of this manuscript.

3.6. Acknowledgments (if applicable)

Acknowledgments follow the “Compliance with ethical principles” section and may be written in a free-form format.

4. References

The Vancouver citation style is used for formatting the reference list (https://en.wikipedia.org/wiki/Vancouver_system).

References to unpublished works or dissertation abstracts are not permitted. References to textbooks, manuals, reference books, or state standards (GOSTs) are discouraged; if necessary, such documents should be formatted as footnotes.

The reference list for original research and clinical cases should not exceed 25–30 sources; for reviews, it should not exceed 60 sources.

All bibliographic details must be carefully verified against the original source. Authors are solely responsible for any errors. If errors are detected or in case of disputed issues, the Editorial Office reserves the right to request the full texts of the cited articles from the authors.

References must be numbered sequentially in the order they are first cited in the manuscript. In the text, citations are indicated by the sequential number in square brackets: [1], [1, 2], or [1–4]. Each reference in the list must start on a new line. All documents cited in the text must be included in the reference list.

If authors' names are cited directly in the text, use the first author's last name with initials for Russian authors or only the last name in the original language for foreign authors.

Example of text formatting: “...as shown in the work of Smith et al., as shown in the study by N. N. Nikolaeva and colleagues.”

The reference list includes the names of all authors up to three; if there are more than three authors, “et al.” must follow for all publications (both Russian and foreign).

Russian-language sources must be presented with transliteration: first the original Russian reference, followed immediately by the transliterated English version.

For all sources, a DOI (if available) and EDN (if available) must be provided. For electronic resources, a stable URL link and the exact date of access must be included.

Examples of Reference Formatting

Citation of an article (English):

Li N, Kang H, Liu Z, et al. Association of maternal phthalates exposure and metabolic gene polymorphisms with congenital heart diseases: a multicenter case-control study. BMC Pregnancy Childbirth. 2024;24(1):167. https://doi.org/10.1186/s12884-024-06343-z

Citation of an article (Russian):

Цепокина А. В., Хуторная М. В., Шабалдин А. В., Понасенко А. В. Особенности распределения генотипов полиморфных вариантов rs2234246 и rs4711668 TREM-1 у детей с дуктус-зависимыми врожденными пороками сердца. Трансляционная медицина. 2019;6(4):5‒12. https://doi.org/10.18705/2311-4495-2019-6-4-5-12

Tsepokina AV, Khutornaya MV, Shabaldin AV, Ponasenko AV. The role of gene TREM-1 at children who have operation congenital heart diseases. Translational Medicine. 2019;6(4):5‒12. (In Russ.) https://doi.org/10.18705/2311-4495-2019-6-4-5-12

Citation of a whole book (English):

Vanek T, Kohli A. Biochemistry, myoglobin. StatPearls Treasure Island: StatPearls Publishing; 2025. 180 p.

Citation of a whole book (Russian):

Гольдберг Й. Нейросетевые методы в обработке естественного языка. М.: ДМК Пресс; 2019. 282 c.

Goldberg Y. Neural network methods in natural language processing. M.: DMK Press; 2019. 282 p. (In Russ.)

Citation of a book chapter (English):

Mazaffari M, Karapetian M, Akhbertani S, Rashevzadeh A. In Silico tests in advanced anti-cancer strategies. In: Trends and Achievements in Experimental Oncopharmacology. Amir Kabir UTP: Tehran–Shiraz; 2025. Pp. 71–88.

Citation of a book chapter (Russian):

Беленичев И. Ф. Цитокины. В кн. Фармакология. Novosibirsk: «СибАК»; 2013. 194 с.

Belenichev I. F. Cytokines. In: Pharmacology. Novosibirsk: “SibAK”; 2013. 194 p. (In Russ.)

Citation of a Web link (Russian):

Федеральная служба государственной статистики. Заболеваемость населения по основным классам болезней. Доступно по ссылке: https://rosstat.gov.ru/folder/13721 [цитировано 28 апреля 2026]

Federal State Statistics Service. Morbidity of the population by major disease classes. Available from: https://rosstat.gov.ru/folder/13721 [cited 2026 Apr 28]

Citation of a Web link (English):

Piccoli SP. Points to consider document: scientific and regulatory considerations for the analytical validation of assays used in the qualification of biomarkers in biological matrices. Available from: https://media.c-path.org/wp-content/uploads/20240427170639/evidconsid- [cited 2025 Apr 30]

Citation of a patent (Russian):

Абдурасулова И. Н., Тарасова Е. А., Ермоленко Е. И. и др. Применение пробиотического штамма микроорганизма Enterococcus faecium L-3 для лечения нейродегенеративных заболеваний. Патент РФ №2014154366 от 30.12.2014. Опубликован 24.01.2018. Бюл. №3

Abdurasulova IN, Tarasova EA, Ermolenko EI, et al. Use of the probiotic microorganism strain Enterococcus faecium L-3 for treating neurodegenerative diseases. Russian Federation Patent No. 2014154366 dated December 30, 2014. Published January 24, 2018. Bulletin No. 3. (In Russ.)

Citation of a patent (English):

Gupalova TV, Bormotova EA, Leonteva GF, et al. Method of creating a live vaccine against COVID-19 based on the probiotic strain enterococcus faecium l3 and a live vaccine enterococcus faecium L3-PENTF-COVID-19. Patent No. RU2745626C1. Published March 29, 2021. Bulletin No. 10

Citation of conference proceedings:

Antyufeyeva GM, Samko GN, Zolotareva GV, et al. N.V. Sklifosovsky. Scientist, doctor, teacher and public figure (for the 190th Birthday). In: Sklifosovsky Readings. Trends and Achievements of Modern Medicine. Proceedings of the Conference; Tiraspol, November 28–29, 2025. 2025. Pp. 7–11. (In Russ.) https://elibrary.ru/chnxjg

Citation of a dissertation:

Beretar RB. Endovideosurgical Treatment of Hiatal Hernia [dissertation]. Krasnodar: Kuban State Medical University; 2020. 166 p. (In Russ.)

5. Captions for Tables, Graphs, and Figures

Captions must include the measurement units for all indicators and specify the method of data presentation (e.g., M±m; M±SD; Me; Mo; percentiles, etc.). All figures, totals, and percentages must be carefully verified against their mention in the main text. If a reference to a figure or table is embedded within a sentence, the full word must be used (“Figure 1”, “Table 1”); if enclosed in parentheses, abbreviations must be used: (Fig. 1), (Table 1). If a figure consists of multiple parts, they should be labeled with lowercase letters (a, b, c, d, etc.), and each part must be explicitly referenced in the text: (Fig. 1, a), (Fig. 1, b). Each caption must include an English translation. When translating lettered labels, if they are marked on a diagram/figure, the original letters (А, Б, В / а, б, в, г) are retained. If only one figure and one table are included in the article, they do not require numbering, and only their titles are specified.

6. Formatting Graphs, Diagrams, and Figures

Tables (doc/docx), graphs, diagrams, and figures (TIFF, JPEG formats, with a resolution of at least 300 dpi) must be submitted as separate files. Photographs must be high-contrast, and drawings must be clear. Microphotographs must include a scale bar, and the magnification factor must be specified in the caption (provided on a separate sheet). Figures, tables, and diagrams should be sequentially referred to in the text according to their placement (e.g., Figure 1, Table 1, Scheme 1). The use of color is highly preferred for graphs, diagrams, and figures.

7. Author Information

Following the reference list, information about all authors must be provided, including: full name, academic degrees/titles, current positions, institutional affiliations (using the accepted standard abbreviated name), city, country, email address, and ORCID iD.

Example:

Name P. Surname – MD, PhD, Associate Professor, Head (etc.), V. A. Almazov NMRC, St. Petersburg, Russia, fake@2026yandex.ru, ORCID 0000-0000-0000-0000;

8. Authors' Contributions

Each author's specific contribution must be explicitly stated. Contributions cannot be identical or fully equivalent; all actions performed on the manuscript by each participant must be listed. Authors may use the sample wording accepted by the editorial office.

Example:

Ivanov I. I. – collection and analysis of material, writing the manuscript; Sidorov S. S. – study design, compilation of references, writing the manuscript; Petrov P. P. – research supervision, approval of the final manuscript version, reviewing and editing the manuscript, etc.

Manuscript Preparation Stages and Timelines

The overall average time from submission to publication is 2–9 months. Each article undergoes the following stages:

Stage 1. Submission to the Editorial Office. At this initial stage, all accompanying documents and text originality are verified using the Anti-Plagiarism system. Review at this stage typically takes no more than one working day (responsible person: Executive Secretary of the journal).

Stage 2. Peer Review. Upon successful completion of the first stage, the manuscript is sent for peer review. Each article undergoes a double-blind peer review process. The duration of the review depends on the experts' availability and agreement to provide a comprehensive evaluation. The standard review period is 2 to 4 weeks but may be extended upon the reviewer's request. After receiving at least two complete reviews, the Editorial Board, Scientific Editor, and Editor-in-Chief make a combined decision on whether to accept or reject the article (responsible person: Scientific Editor of the journal).

Stage 3. Manuscript Revision. Based on the received reviews, the Editor-in-Chief decides whether to require minor/major revisions, a complete re-review, or accept the article for publication. Authors are typically granted 14 to 30 calendar days to complete revisions. If authors fail to respond or establish contact for more than 30 days, the manuscript is automatically withdrawn from consideration. Following successful revision, a final decision on the acceptance of the article for publication is made (responsible person: Editor-in-Chief of the journal).

Stage 4. In-House Processing. The technical preparation of the article by the editorial and publishing department takes up to 14 days. At this stage, the manuscript undergoes scientific and technical editing, proofreading, literary editing, layout design, and final proofreading (responsible person: Executive Secretary of the journal).

For any inquiries, please contact the editorial office: bulleten@almazovcentre.ru (editorial office email); sukhorukova_aa@almazovcentre.ru (Executive Secretary's email).

Possible Reasons for Manuscript Rejection:

• the article's content does not match the journal's scientific scope;
• the manuscript is not original research (exceeded the allowed percentage of self-citation or improper citation);
• the article or significant fragments of the text have been previously published in other editions;
• the manuscript received negative peer reviews;
• based on the final consensus decision of the editorial board;
• detected violations of ethical standards;
• authors fail to respond to editorial correspondence for more than 1 month.

Copyright Notice

Authors who publish with this journal agree to the following terms:

1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

Privacy Statement

Specified when registering the names and addresses will be used solely for technical purposes of a contact with the Author or reviewers (editors) when preparing the article for publication. Private data will not be shared with other individuals and organizations.